Treats schizophrenia. ANDA 202873, held by Accord Hlthcare. Clozapine.
As of Nov 15, 2026, ANDA 202873 (Clozapine), held by Accord Hlthcare, was first approved by FDA on Nov 25, 2015, with 13 approved supplements and 0 published complete response letters.
Clozapine tablets is an atypical antipsychotic indicated for: Treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. Because of the risks of severe neutropenia and of seizure associated with its use, clozapine tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment. Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior. 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 25, 2015 | Original application | Approved |
| Oct 2, 2026 | Supplement 21Labeling · Standard review | Approved | None posted |
| Oct 2, 2026 | Supplement 18Labeling · Standard review | Approved | None posted |
| Oct 2, 2026 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jun 13, 2025 | Supplement 19REMS | Approved | None posted |
| Mar 6, 2024 | Supplement 15Labeling · Standard review | Approved | None posted |
| Mar 6, 2024 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 6, 2024 | Supplement 13Labeling · Standard review | Approved | None posted |
| Mar 6, 2024 | Supplement 7Labeling · Standard review | Approved | None posted |
| Mar 6, 2024 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 10, 2021 | Supplement 11REMS | Approved | None posted |
| Jul 29, 2021 | Supplement 10REMS | Approved | None posted |
| Feb 18, 2021 | Supplement 8REMS | Approved | None posted |
| Jan 16, 2019 | Supplement 5REMS | Approved | None posted |
| Nov 25, 2015 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters